# US 2019/0314549 A1 · Demineralized bone fibers and preparation thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0314549 A1
- Document ID: US20190314549A1
- Status: Published application
- Kind: A1
- Application number: 16/309,505
- Filed: 2017-06-13
- Published: 2019-10-17
- Earliest claimed: 2016-06-13
- Assignees: LifeNet Health
- Applicants: LifeNet Health
- Inventors: Silvia Chen; Grant Cleavenger; Dennis Phelps; Evans Wralstad; Breanne Gjurich; Austin Johnson; Alana Sampson; Adam Entsminger; Jingsong Chen
- Web page: https://patentgrep.com/patent/US20190314549A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61F 2/4644: {Preparation of bone graft, bone plugs or bone dowels, e.g. grinding or milling bone material (bone material A61F2/28; disintegrating or milling devices B02C)}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61K 38/1875: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
- A61L 27/365: {Bones}
- A61L 27/3683: {subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment}
- A61L 27/3687: {characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents}
- A61L 27/3821: {Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells}
- A61L 27/3834: {Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells}
- A61L 27/3847: {Bones}
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides demineralized bone fibers exhibiting optimal handling properties (e.g., high moldability and low elastic modulus) and biological activities (e.g., osteoinductivity) as well as non-demineralized bone fibers useful for preparing the demineralized bone fibers. A well-controlled demineralization process for preparing the demineralized bone of fibers is also provided. Products comprising the demineralized bone fibers and uses thereof are further provided.

## Claims

### Claim 1

A method for preparing a demineralized bone graft, wherein the demineralized bone graft has a residual calcium content of less than 6 wt % based on the dry weight of the demineralized bone graft, comprising subjecting a non-demineralized bone graft to a single incubation in an acid solution for no more than 300 seconds, wherein the acid solution has a pH of 0-4.

### Claim 2 (depends on 1)

The method of claim 1, wherein the non-demineralized bone graft comprises bone fibers, bone particles, bone sheets, bone cubes, bone shafts, or a combination thereof.

### Claim 3 (depends on 1)

The method of claim 1, wherein the non-demineralized bone graft comprises non-demineralized bone fibers, and wherein the demineralized bone graft comprises demineralized bone fibers.

### Claim 4 (depends on 3)

The method of claim 3, wherein the demineralized bone fibers are osteoinductive.

### Claim 5 (depends on 3)

The method of claim 3, wherein the non-demineralized bone fibers have an average shortest dimension of less than 200 μm.

### Claim 6 (depends on 3)

The method of claim 3, wherein the demineralized bone fibers have an elastic modulus of less than 100.00 kPa.

### Claim 7 (depends on 3)

The method of claim 3, further comprising adding an effective amount of a buffer to the acid solution after the single incubation.

### Claim 8 (depends on 7)

The method of claim 7, wherein the pH of the resulting solution is adjusted to 2.5-7 within 90 seconds after the addition of the buffer.

### Claim 9 (depends on 3)

The method of claim 3, further comprising storing the demineralized bone fibers in a storage solution, wherein the storage solution is glycerol, a buffer, or a cryopreservation solution.

### Claim 10 (depends on 3)

The method of claim 3, further comprising drying the demineralized bone fibers.

### Claim 11 (depends on 3)

The method of claim 3, further comprising releasing at least 75 wt % of calcium in the non-demineralized bone fibers.

### Claim at position 12

12-13. (canceled)

### Claim 14 (depends on 3)

A composition comprising the demineralized bone fibers produced by the method of claim 3.

### Claim 15

A composition comprising demineralized bone fibers having a residual calcium content of less than 6 wt % based on the dry weight of the demineralized bone fibers, wherein the demineralized bone fibers are osteoinductive, and wherein the demineralized bone fibers have an elastic modulus of less than 100.00 kPa.

### Claim at position 15

16-21. (canceled)

### Claim 22 (depends on 14)

An implant comprising the composition of claim 14.

### Claim at position 17

23-24. (canceled)

### Claim 25 (depends on 14)

A package comprising the composition of claim 14.

### Claim at position 19

26-27. (canceled)

### Claim 28 (depends on 14)

A method for promoting osteoinductivity, osteoconductivity, chondroinductivity, chondroconductivity, or fibrochondral differentiation in entheses, comprising incubating cells with an effective amount of the composition of claim 14.

### Claim at position 21

29-32. (canceled)

### Claim 33 (depends on 14)

A method for promoting cell attachment, proliferation, maintaining a differentiation state or preventing de-differentiation of cells, comprising incubating cells with an effective amount of the composition of claim 14.

### Claim 34 (depends on 14)

A method for promoting osteogenesis, chondrogenesis, or fibrocartilage tissue genesis in cells, comprising incubating the cells with an effective amount of the composition of claim 14.

### Claim 35 (depends on 14)

A method for treating a tissue or organ defect in a subject, comprising applying to the site of the defect an effective amount of the composition of claim 14.

### Claim 36

A composition comprising demineralized bone fibers having a residual calcium content of between 0.5-6 wt % based on the dry weight of the demineralized bone fibers, wherein the demineralized bone fibers are osteoinductive, wherein the demineralized bone fibers have a specific surface area of at least 100 cm2/g.

### Claim at position 26

37-39. (canceled)
